Intelligence · Clinical pipeline
Infectious disease R&D Pipeline
Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
Quick answer
Infectious disease: NovaPharmaNews indexes 1,112 infectious disease clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Antiviral, antibacterial, and infectious disease vaccine pipeline programs.
Top sponsors
- United Therapeutics Europe 94 programs
- BRIGHT MINDS BIOSCIENCES 81 programs
- Chinese Academy of 77 programs
- Sinovac Research and 49 programs
- GSK Glaxo Smith 39 programs
- Takeda 33 programs
- First People's Hospital 31 programs
- Vertex Pharmaceuticals (Australia) 30 programs
- Vir Biotechnology 26 programs
- George Institute for 25 programs
- ENANTA PHARMACEUTICALS 22 programs
- Hospital Authority 22 programs
Pipeline programs
-
MGL-3196
Madrigal Pharmaceuticals EU Limited
NASH - Nonalcoholic Steatohepatitis
1 trial -
MGL-3196-11
Madrigal Pharmaceuticals EU Limited
Non-Alcoholic Steatohepatitis (NASH)
1 trial -
MGL-3196-19
Madrigal Pharmaceuticals EU Limited
Non-alcoholic Steatohepatitis (NASH) Cirrhosis
1 trial -
MK-4482-023
Merck Sharp and Dohme
SARS-CoV-2 (COVID-19) infection
1 trial -
MK-8527
Merck KGaA, Darmstadt, Germany
Human Immunodeficiency Virus (HIV)
1 trial -
MK-8527-011
Merck Sharp and Dohme
HIV-1 prevention
1 trial -
MK-8591A
Merck Sharp and Dohme
HIV infection
1 trial -
MK-8591A-053
Merck Sharp and Dohme
HIV-1 Infection
1 trial -
MK-8591B-062
Merck Sharp and Dohme
HIV
1 trial -
MP-424
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
2 trials -
MP-424
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial -
Medium-dosage COVID-19 Vaccine,Inactivated
Sinovac Research and Development Co.,
COVID-19
1 trial -
Mencevax ACWY
GlaxoSmithKline
Infections, Meningococcal
1 trial -
Meningococcal vaccine GSK134612
GlaxoSmithKline
Infections, Meningococcal
2 trials -
Mirasol-treated Fresh Whole Blood
United Therapeutics Europe Ltd
Transfusion-Transmitted Infectious Disease
1 trial -
Molnupiravir
Merck KGaA, Darmstadt, Germany
Coronavirus Disease (COVID-19)
2 trials -
Motivational interviewing
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
NCT02735707
Disc Medicine
Respiratory tract infection
1 trial -
NGAM-12
Maze Therapeutics
Primary infection prophylaxis in patients with chronic lymphocytic leukemia (CLL) and secondary hypogammaglobulinemia.
1 trial -
NGAM-16
Maze Therapeutics
Prevention of a Major infection in patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions receiving treatment with B-cell depletion therapy.
1 trial -
NN9931-4553
NovoThirteen
Non-alcoholic steatohepatitis (NASH)
1 trial -
Nanocovax
Biotech Pharmaceutical Co.,
SARS-CoV-2 Infection
1 trial -
Niclosamide
United Therapeutics Europe Ltd
Covid19
1 trial -
Nimenrix
GlaxoSmithKline
Infections, Meningococcal
1 trial -
OP0595-5
Lacuna Pharma Pty Ltd
Complicated urinary tract infection (cUTI) and acute uncomplicated pyelonephritis (AP)
1 trial -
OP0595-6
Lacuna Pharma Pty Ltd
Complicated urinary tract infection (cUTI), acute uncomplicated pyelonephritis (AP), hospital acquired bacterial pneumonia (HABP), ventilator-associated bacterial pneumonia (VABP), and complicated intra-abdominal infection (cIAI)
1 trial -
On-site bundled rapid HIV/HCV testing
BRIGHT MINDS BIOSCIENCES INC.
Substance-related Disorders
1 trial -
One4All
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
Opaganib
RedHill Biopharma
COVID-19
2 trials -
PCV21
Sanofi Pasteur
Pneumococcal Infections
1 trial -
PEG-Interferon a-2b + Ribavirin
Universal Integrated
Chronic Hepatitis C Infection in HIV-Infected Persons
1 trial -
PEG-interferon-Alfa-2A
Hospital Authority, Hong Kong
Chronic Hepatitis B
1 trial -
PF-07321332
Pfizer
COVID-19
2 trials -
PRO 2000/5
United Therapeutics Europe Ltd
HIV Infections
1 trial -
PRO-nCOV-3001
Sinovac Research and Development Co.,
Covid19
1 trial -
PRO-onCOV-3001
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-tnCOV-3003
Sinovac Research and Development Co.,
COVID-19
1 trial -
Paeoniflorin + phosphatidylcholine or silymarin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis, Autoimmune
1 trial -
Part A: Upamostat 200 mg
RedHill Biopharma
Covid19
1 trial -
Peer HIV Education Program
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
Peer Mentoring Intervention for HCV-Infected IDUs
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis C
1 trial -
Peg interferon alpha-2b
Universal Integrated
Hepatitis C
1 trial -
PegIntron (peginterferon alfa-2b)
Universal Integrated
Hepatitis C, Chronic
1 trial -
Pegylated Interferon Alfa 2a
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
Pegylated Interferon Alfa 2a
Vertex Pharmaceuticals (Australia) Pty.
Infection
1 trial -
Permethrin, InfectoScab® 5 % Crème
Alphapharm Pty Ltd
Scabies
1 trial -
Pioglitazone
Takeda
HIV-Associated Lipodystrophy Syndrome
1 trial -
Placebo
GlaxoSmithKline
Infections, Papillomavirus
1 trial
Frequently asked questions
How many infectious disease pipeline programs are tracked?
1,112 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.